These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. Gangrene after penicillin injection (a case report). Ozel A; Yavuz H; Erkul I Turk J Pediatr; 1995; 37(1):67-71. PubMed ID: 7732611 [TBL] [Abstract][Full Text] [Related]
64. A precarious balancing act--the role of the FDA as protector of public health and industry wealth. McCabe AR Suffolk Univ Law Rev; 2003; 36(3):787-819. PubMed ID: 16493844 [No Abstract] [Full Text] [Related]
65. In brief: intravenous ondanstron (Zofran) 32 mg withdrawn. Med Lett Drugs Ther; 2012 Dec; 54(1406):104. PubMed ID: 23282793 [No Abstract] [Full Text] [Related]
66. Effect of drug industry marketing practices on formularies questioned by federal agencies. Gatty B Hosp Formul; 1994 Nov; 29(11):786, 785. PubMed ID: 10138576 [No Abstract] [Full Text] [Related]
67. Limiting State Flexibility in Drug Pricing. Bagley N; Sachs RE N Engl J Med; 2018 Sep; 379(11):1002-1004. PubMed ID: 30207910 [No Abstract] [Full Text] [Related]
70. Inadvertent intra-arterial injection of flucloxacillin. Zideman DA; Morgan M Anaesthesia; 1981 Mar; 36(3):296-8. PubMed ID: 7224122 [TBL] [Abstract][Full Text] [Related]
71. The risk of risk reduction: can postmarket surveillance pose more risk than benefit? Hall RF Food Drug Law J; 2007; 62(3):473-92. PubMed ID: 17915389 [No Abstract] [Full Text] [Related]
72. Promethazine adverse events after implementation of a medication shortage interchange. Sheth HS; Verrico MM; Skledar SJ; Towers AL Ann Pharmacother; 2005 Feb; 39(2):255-61. PubMed ID: 15644479 [TBL] [Abstract][Full Text] [Related]
73. User-fee bill passes US Senate, but legislative hurdles remain. Fox JL Nat Biotechnol; 2007 Jun; 25(6):611. PubMed ID: 17557086 [No Abstract] [Full Text] [Related]
74. Fifty years of cosmetic safety: a government and industry partnership. Donegan TJ Food Drug Law J; 1995; 50 Spec():151-62. PubMed ID: 10343040 [No Abstract] [Full Text] [Related]
75. A patient's right of privacy in computerized pharmacy records. Mowery G Univ Cincinnati Law Rev; 1998; 66(2):697-746. PubMed ID: 16211743 [No Abstract] [Full Text] [Related]
77. Corporate responsibility for recombinant DNA activities. Berger BA Univ Toledo Law Rev; 1981; 12(4):913-24. PubMed ID: 11649592 [No Abstract] [Full Text] [Related]
78. Colacicco v Apotex Inc. and the federal preemption of state tort remedies for health injuries: implications for public health policy and practice. Burke T Public Health Rep; 2009; 124(1):160-3. PubMed ID: 19413038 [No Abstract] [Full Text] [Related]
79. Drug review "behind the curtain": a response to Professor Struve. O'Reilly JT Cornell Law Rev; 2008 Jul; 93(5):1075-90. PubMed ID: 18618971 [No Abstract] [Full Text] [Related]